NovaBay Pharma (NBY) Reports In-Line Q4 EPS, Revenues Miss

Go back to NovaBay Pharma (NBY) Reports In-Line Q4 EPS, Revenues Miss

NovaBay Pharmaceuticals Reports 2020 Fourth Quarter and Full Year Financial Results

March 25, 2021 4:05 PM EDT

Avenova® unit sales set record for second consecutive quarter Net product revenue increased 51% for 2020 Exited 2020 with $12.0 million in cash and equivalents Avenova access expanded to CVS stores and CVS online

Conference call begins at 4:30 p.m. Eastern time today

EMERYVILLE, Calif.--(BUSINESS... More